B. Ostendorf

Systemic lupus erythematosus

Structural Basis for Recognizing Phosphoarginine and Evolving Residue-Specific Protein Phosphatases in Gram-Positive Bacteria

The IL-1 family of cytokines and receptors in rheumatic diseases

The JAK/STAT signaling pathway: from bench to clinic

Caspase Functions in Cell Death and Disease

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

New treatments for SLE: cell-depleting and anti-cytokine therapies

At the horizon of innovative therapy in rheumatology: new biologic agents

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

The Complex Role of Estrogens in Inflammation

Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease

Sex hormones in the pathogenesis of systemic lupus erythematosus

Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis

Hyperprolactinemia in Systemic Lupus Erythematosus?

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis